Chennai-based designer Vivek Karunakaran’s latest collection Idam (Tamil for ‘place’), which debuted in Feb at the FDCI India ...

Tamil Nadu Class 12th Result 2025 Highlights: The Directorate of Government Examinations (DGE), Tamil Nadu has declared the Class 12 results for 2025. Students can check their results on the ...

Trade, Industry and Competition Minister Parks Tau outlines his vision for the proposed Transformation Fund during a briefing in Johannesburg. Camera Work & Editing: Shadwyn Dickinson. Recorded ...

Until now, scientists did not fully understand what tau protein aggregates were doing in the brain's blood vessels.To uncover the mystery, Dr. Fossati and graduate student Roberto Guzmán ...

As part of this collaboration, the parties have entered into a comprehensive three-year service agreement whereby Oramed will provide Alpha Tau with investor and shareholder outreach, business ...

Ajith Kumar came and conquered the box office in the true sense! After Vidaamuyarchi, the South superstar arrived with the Tamil action comedy Good Bad Ugly. It is currently the highest-grossing ...

Puthandu 2025: Puthandu, the Tamil New Year is being celebrated today. Puthandu 2025: Puthandu, also known as the Tamil New Year is celebrated to mark the beginning of a new calendar year for the ...

Tamil New Year 2025: Puthandu, also known as Tamil New Year or Varusha pirappu, is the first day of year on the Tamil calendar which is going to be celebrated on Monday, April 14, with great ...

Abnormal accumulation of tau protein in the brain has been associated with neurodegeneration and cognitive decline in AD patients. BIIB080 is an investigational antisense oligonucleotide therapy ...

The misfolded proteins tau and α-syn cause irregular aggregation and spread in neurodegenerative illnesses, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In AD, tau protein ...

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s disease drug candidate on the cusp of the release of phase 2a data.

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.